Chinook Therapeutics, Inc. (KDNY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Chinook Therapeutics, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.14x | -7.34x | -2.56x | -5.31x | -10909.78x | -29759.48x |
| P/B Ratio | 3.82x | 1.64x | 0.62x | -6.05x | 7688.39x | 11512.03x |
| P/S Ratio | 275.21x | 14.41x | 252.53x | 14.41x | 68954.98x | 158582.03x |
| Profitability | ||||||
| Gross Margin | 71.9% | 96.7% | 49.0% | 96.8% | 96.1% | 96.8% |
| Operating Margin | -3020.3% | -191.8% | -6798.9% | -115.7% | -671.8% | -617.5% |
| Net Margin | -3012.6% | -196.2% | -9869.6% | -271.5% | -632.0% | -532.9% |
| EBITDA Margin | -2679.4% | -110.7% | -6527.4% | -112.7% | -671.8% | -617.5% |
| Liquidity | ||||||
| Current Ratio | 7.59x | 7.50x | 11.14x | 5.16x | 9.27x | 8.46x |
| Quick Ratio | 7.59x | 7.50x | 11.14x | 6.39x | 9.27x | 8.46x |
| Leverage | ||||||
| Debt/Equity | 0.09x | 0.10x | 0.12x | -0.05x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..